Thus, our data suggested that SPINK1 expression level in tumour stroma can act as an SASP-associated independent predictor of prognosis, which is exploitable in stratifying the risk of disease relapse and clinical mortality in post-treatment patients, and that SPINK1 production by stroma may have a causal role in tumour progression. Here, SPINK1 is linked to neoplasm.